Detalles de la búsqueda
1.
Efficacy of pneumococcal nontypable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in young Latin American children: A double-blind randomized controlled trial.
PLoS Med
; 11(6): e1001657, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24892763
2.
Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial.
Lancet
; 381(9862): 214-22, 2013 Jan 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-23158882
3.
Correction: Efficacy of Pneumococcal Nontypable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) in Young Latin American Children: A Double-Blind Randomized Controlled Trial.
PLoS Med
; 12(6): e1001850, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26115379
4.
Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trials.
Lancet
; 374(9698): 1339-50, 2009 Oct 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-19837254
5.
Safety and reactogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with routine childhood vaccines.
Pediatr Infect Dis J
; 28(4 Suppl): S109-18, 2009 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-19325447
6.
Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine.
Pediatr Infect Dis J
; 28(4 Suppl): S66-76, 2009 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-19325449
7.
The 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) coadministered with DTPw-HBV/Hib and poliovirus vaccines: assessment of immunogenicity.
Pediatr Infect Dis J
; 28(4 Suppl): S89-96, 2009 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-19325451
8.
Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study.
Lancet
; 367(9512): 740-8, 2006 Mar 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-16517274
9.
Efficacy of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine against acute otitis media and nasopharyngeal carriage in Panamanian children - A randomized controlled trial.
Hum Vaccin Immunother
; 13(6): 1-16, 2017 06 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28368738
10.
Effectiveness of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D-Conjugated Vaccine (PHiD-CV) Against Carriage and Acute Otitis Media-A Double-Blind Randomized Clinical Trial in Finland.
J Pediatric Infect Dis Soc
; 5(3): 237-248, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27125273
11.
Effect of pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) on outpatient antimicrobial purchases: a double-blind, cluster randomised phase 3-4 trial.
Lancet Infect Dis
; 14(3): 205-12, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24287186
12.
Impact of the 10-valent pneumococcal non-typeable Haemophilus influenzae Protein D conjugate vaccine (PHiD-CV) on bacterial nasopharyngeal carriage.
Vaccine
; 29(10): 1959-67, 2011 Feb 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-21215830
13.
Safety and immunogenicity of a booster dose of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine coadministered with measles-mumps-rubella-varicella vaccine in children aged 12 to 16 months.
Pediatr Infect Dis J
; 29(6): e47-56, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20508478
14.
Immunogenicity of a 2-dose priming and booster vaccination with the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine.
Pediatr Infect Dis J
; 28(10): e276-82, 2009 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-20118683
15.
Safety of the 11-valent pneumococcal vaccine conjugated to non-typeable Haemophilus influenzae-derived protein D in the first 2 years of life and immunogenicity of the co-administered hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio virus, Haemophilus influenzae type b and control hepatitis A vaccines.
Vaccine
; 26(35): 4563-70, 2008 Aug 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-18602724
Resultados
1 -
15
de 15
1
Próxima >
>>